Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly

ABSTRACT Purpose: This study aimed to ascertain the efficacy and safety of remimazolam besylate and ciprofol in elderly patients undergoing painless gastrointestinal endoscopy. Methods: Patients in the control group (n = 31) were anesthetized with ciprofol, and those in the observation group (n =...

Full description

Saved in:
Bibliographic Details
Main Author: Ziwei Zhu
Format: Article
Language:English
Published: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2024-12-01
Series:Acta Cirúrgica Brasileira
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502024000100815&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846119037793206272
author Ziwei Zhu
author_facet Ziwei Zhu
author_sort Ziwei Zhu
collection DOAJ
description ABSTRACT Purpose: This study aimed to ascertain the efficacy and safety of remimazolam besylate and ciprofol in elderly patients undergoing painless gastrointestinal endoscopy. Methods: Patients in the control group (n = 31) were anesthetized with ciprofol, and those in the observation group (n = 31) were anesthetized with remimazolam besylate. The anesthetic effect, analgesic effect, hemodynamics, cognitive function, and adverse reactions between the two groups were compared. Results: The observation group had shorter anesthesia onset time, recovery time, as well as anesthesia recovery room stay time and a higher effective rate of analgesia. At T1, T2, and T3, the mean arterial pressure and heart rate of the observation group were higher versus the control group; at T1 and T2, SpO2 in the observation group was higher versus the control group. The simple mental state scale score of the observation group was higher than that of the control group (all p 0.05). The total incidence of adverse reactions exhibited no difference between the two groups (p> 0.05). Conclusion: Versus ciprofol, remimazolam besylate has better anesthetic and analgesic effects, more stable hemodynamics, less impact on patients’ cognitive function, and good safety in elderly patients undergoing painless gastrointestinal endoscopy.
format Article
id doaj-art-7ff0c5c7df3b45b985766af8dc8da31c
institution Kabale University
issn 1678-2674
language English
publishDate 2024-12-01
publisher Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
record_format Article
series Acta Cirúrgica Brasileira
spelling doaj-art-7ff0c5c7df3b45b985766af8dc8da31c2024-12-17T08:00:35ZengSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaActa Cirúrgica Brasileira1678-26742024-12-013910.1590/acb399324Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderlyZiwei Zhuhttps://orcid.org/0009-0008-6714-6406ABSTRACT Purpose: This study aimed to ascertain the efficacy and safety of remimazolam besylate and ciprofol in elderly patients undergoing painless gastrointestinal endoscopy. Methods: Patients in the control group (n = 31) were anesthetized with ciprofol, and those in the observation group (n = 31) were anesthetized with remimazolam besylate. The anesthetic effect, analgesic effect, hemodynamics, cognitive function, and adverse reactions between the two groups were compared. Results: The observation group had shorter anesthesia onset time, recovery time, as well as anesthesia recovery room stay time and a higher effective rate of analgesia. At T1, T2, and T3, the mean arterial pressure and heart rate of the observation group were higher versus the control group; at T1 and T2, SpO2 in the observation group was higher versus the control group. The simple mental state scale score of the observation group was higher than that of the control group (all p 0.05). The total incidence of adverse reactions exhibited no difference between the two groups (p> 0.05). Conclusion: Versus ciprofol, remimazolam besylate has better anesthetic and analgesic effects, more stable hemodynamics, less impact on patients’ cognitive function, and good safety in elderly patients undergoing painless gastrointestinal endoscopy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502024000100815&lng=en&tlng=enEndoscopy, GastrointestinalHemodynamicsCognitionAnesthetics
spellingShingle Ziwei Zhu
Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
Acta Cirúrgica Brasileira
Endoscopy, Gastrointestinal
Hemodynamics
Cognition
Anesthetics
title Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
title_full Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
title_fullStr Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
title_full_unstemmed Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
title_short Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
title_sort efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly
topic Endoscopy, Gastrointestinal
Hemodynamics
Cognition
Anesthetics
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502024000100815&lng=en&tlng=en
work_keys_str_mv AT ziweizhu efficacyandsafetyofremimazolambesylateandciprofolinpainlessgastrointestinalendoscopyintheelderly